Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-08Osimertinib With Chemotherapy as First-line Therapy for Patients With Locally Advanced or Metastatic Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-Small Cell Lung Cancer (NSCLC): A Multicentre, Observational Study (FOREFRONT)
-
CLINICAL_TRIALS study record update · 2026-01-08Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female
-
CLINICAL_TRIALS study record update · 2026-01-08A Phase I Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of MRX-2843 in Adult Subjects With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-01-07Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-01-07E-CANE: a National Program of Remote Health Education Workshops for Adolescents and Young Adults With Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-07A Phase 1b/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-01-06Phase I Study of the Administration of T Lymphocytes Co-Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-06Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-05Monocentric Randomized Study Evaluating the Impact of an Early Multidisciplinary Program in Elderly Subjects Starting a Chemotherapy for Digestive Cancer: Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
-
CLINICAL_TRIALS study record update · 2025-12-31A Study of the Clinical Application of [18F]RCCB6 PET/ CT Imaging in the Diagnosis of Kidney Cancer
-
CLINICAL_TRIALS study record update · 2025-12-31A Multilevel Intervention (Potlako+) to Improve Timely Cancer Detection and Treatment
-
CLINICAL_TRIALS study record update · 2025-12-26A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2025-12-24Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC
-
CLINICAL_TRIALS study record update · 2025-12-24A Pilot Randomized Factorial Trial to Promote Physical Activity and Healthy Eating Among Young Adult Cancer Survivors
-
CLINICAL_TRIALS study record update · 2025-12-19An Open Label, Phase I Study of BI 754091 Monotherapy and Combination Therapy of BI 754091 and BI 754111 in Asian Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2025-12-18Implementing VTE Prevention in Ambulatory Cancer Care
-
CLINICAL_TRIALS study record update · 2025-12-18A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of GSK5764227 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-12-18A Phase 1, First-in-Human, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64619178, an Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) in Subjects With Advanced Cancers
-
CLINICAL_TRIALS study record update · 2025-12-15A Feasibility Study of Mobile Sensor Technologies to Assess General Symptomology of Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-12-10Promoting Physical Activity in Individuals With Cancer in an Oncology Day Clinic - Testing the Feasibility of the Implementation of a Physical Activity Concept Within an Interprofessional Team Led by Nurses OnkoMoveNurse - Proof of Concept
-
CLINICAL_TRIALS study record update · 2025-12-10The Safety and Efficay Investigation of IL-5 CAR-T Cell Therapy for Patients With Refractory/Relapsed Eosinophilic Leukemia
-
CLINICAL_TRIALS study record update · 2025-12-05An Observational Study of the Efficacy and Safety of Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-12-03Feasibility of Expressive Helping for Chinese-Speaking Cancer Patients and Survivors
-
CLINICAL_TRIALS study record update · 2025-11-26Addressing Cancer-Related Financial Toxicity in Rural North Carolina Oncology Care Settings
-
CLINICAL_TRIALS study record update · 2025-11-14A Phase 1 Dose Escalation and Expansion Study of EO-3021, an Anti-claudin 18.2 (CLDN18.2) Antibody Drug Conjugate, in Patients With Solid Tumors Likely to Express CLDN18.2